INmune Bio(INMB) - 2022 Q2 - Earnings Call Transcript

INmune Bio, Inc. (NASDAQ:INMB) Q2 2022 Earnings Conference Call August 3, 2022 4:30 PM ET Company Participants David Moss – Co-Founder and Chief Financial Officer RJ Tesi – Co-Founder and Chief Executive Officer Mark Lowdell – Co-Founder and Chief Scientific Officer Conference Call Participants Tom Shrader – BTIG William Wood – B. Riley Daniel Carlson – TW Research Group Operator Greetings, and welcome to the INmune Bio Second Quarter 2022 Earnings Call. At this time, all participants are in a listen-only m ...